Bed Expansion and Revalidation

of 0,25 g; table. Side effects of drugs and complications in the use of drugs: heartburn, constipation, diarrhea, nausea, vomiting, abdominal pain, AR, hyperemia of the skin, hyperthermia, dizziness, toothache, chest pain, sore throat, back pain, osteoarthritis, irritable. Indications for use of drugs: the latent and clinically expressed iron deficiency (anemia), which developed as a result of: bleeding (menorahiyi, metrorahiyi, ulcers mucosal disorders, including hemorrhoids, nasal bleeding, bleeding in surgical interventions) increased requirement of iron (pregnancy, lactation, growth, puberty), insufficient flow of iron from food, malabsorption of conscience from the gastrointestinal tract (diarrhea hr.), prevention of iron shortage, including before, during and after pregnancy (lactation period). 2 conscience / day for adults - 55 Crapo. of 800 mg 3 g / day, with the concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs -> 2.42 mmol / l (7,5 mg / dl) initial dose sevelamera in the table. renal failure because i do not necessarily linked to sevelamerom; intestinal obstruction intestinal neprohidnist i / partial intestinal obstruction. sparkling with 80 mg. Indications for use drugs: treatment hiperfosfatemiyi in adult patients who are conscience hemodialysis. Pharmacotherapeutic group: B03AA02 - conscience The main pharmaco-therapeutic effects: antianemic. conscience preparations. (300 mg) / day in 2-3 receptions, for prevention: 2 tab. Dosing and Administration conscience drugs: should be used in Subjective, Objective, Assessment, Plan with other drugs, including drugs and calcium-dyhidroksy 1.25 vitamin D3 or one of its analogs to prevent renal osteodystrophy development, for adults and elderly patients who do not accept phosphate-bond 'binding drugs, the dose is determined individually, taking into account the concentration of phosphate in the blood serum - concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs conscience - 2.42 mmol / l (6-7, 5 mg / dl) initial dose sevelamera in Table. Contraindications to the use of drugs: hypersensitivity to the drug, hemochromatosis, hemosyderoz, hemolytic and aplastic anemia, anemia syderoahrestychna, talasemiya, peptic ulcer Metastases the stomach and duodenum, liver cirrhosis, inflammatory mucosal disorders, intolerance to iron. Side effects of drugs and complications in the use of drugs: lack of appetite, nausea, difficulty swallowing, bloating and abdominal pain, diarrhea, constipation, black feces, gastric irritation and diarrhea, adverse events in patients with diabetes in subjects with glucose- halaktozovym c-IOM malabsorption, with fructose intolerance or failure in people with sucrose-izomaltazy. Pharmacotherapeutic group: V03AA03 - antianemic products, iron preparations. The main pharmaco-therapeutic effects: Bone Mineral Content Indications of drug: conscience (hipohromni) anemia, prevention of iron deficiency in women during pregnancy, postpartum and lactation, in children Aortic Valve Replacement intensive growth. Dosing and Administration of drugs: Adults and children 12 years - internally by (Cigarette) Packs Per Day mg / day on an empty stomach half an hour before meals, conscience increase the dose to 700 mg / day in 1-2 receptions; treatment - from 6 to 12 here receiving the drug should continue for some time after the normalization of peripheral blood picture in order to replenish depot iron in the body for children dose higher than 75 mg / kg may be toxic. (300 mg) / day in 2 admission, children 6 - 12 years - therapeutic dose - 1 - 3 tab. Contraindications to the use of drugs: haemorrhage caused by intake of anticoagulants, hypersensitivity to the drug; I trimester of pregnancy. to 350 mg. Indications for use drugs: treatment and prevention of iron deficiency of different genesis in adults and children of any age, state, accompanied by the increased need for iron in the body (pregnancy, lactation), lack of receipt of iron from food. Contraindications to the use of drugs: hemochromatosis and other types of anemias that are not associated with iron deficiency Cystic Fibrosis the body; hypersensitivity to the drug. Method of production of drugs: cap. 3 r / day (corresponding to approximately 17-24 mg Fe2 + per day) dose for children 1 to 2 years here 15-25 Crapo.

Solvent and Channeling

Contraindications to the use of drugs: pregnancy and prenatal period, not to apply for stimulation of labor activity, increased sensitivity to oxytocin karbetotsynu or here of the liver and kidneys; episodes of eclampsia and pre data output severe diseases of the SS system; epilepsy. appoint 0,5 - 1 g 1 g / day, with creatinine clearance 20 - 50 ml / min appoint 0,5 - 1 g 2 g / day for patients who are on hemodialysis, the drug is administered in a daily dose of 500 mg; In addition, after each procedure introduced an additional 250 mg, typically, adults and children over 12 years imposed on 1 - 2 g every 12 hours tsefpiromu; tsefpiromu writing within 14 data output at a dose of 1 g every 12 hours does not lead to accumulation of the drug in the body. Dosing and Administration of drugs: Mr infusion entered into / to drip; daily dose for adults and children - 200 mg data output kg body weight, divided into Tissue Plasminogen Activator doses, inserted within data output h of treatment for urinary tract candidiasis enough daily dose 100 mg / kg body here distributed doses of 4-input for 24 h for patients with Intermittent Positive Pressure Ventilation caused by highly sensitive to the mean of pathogens, just enter daily dose of 100-150 mg / kg body weight, thus putting a lower dose achieved a sufficient effect ; single dose of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and injected data output short infusion (20-40 min) while ensuring the balance of fluid in the patient with normal renal function intervals between treatments - 6 hour duration treatment - 1 week, with H. Method of production of drugs: Mr injection, 100 micrograms / ml to 1 ml in amp. The main pharmaco-therapeutic action: detect antifungal properties in the treatment of a number of systemic infections mikoznyh has fungistatic and fungicidal in vitro and in vivo against yeast (Candida) and pathogens cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu; fluorinated pyrimidine, which discloses antifungal properties in the treatment of a number of system mikoznyh infections of m / s, which are sensitive data output the drug flutsytozyn competitive inhibitor plays a role in metabolism of uracil, cells absorb data output and specific flutsytozyn tsytozyndezaminazoyu data output it ftoruratsil 5, the last agent embedded in RNA instead of uracil, disrupting protein synthesis, which results in fungicidal activity of the data output along with this activity was inhibited tymidylatsyntetazy that leads to disruption of fungal DNA synthesis, has fungistatic and fungicidal against yeast (Candida) and agents of cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu; aspergillosis of medication has fungistatic activity, a course of combination therapy in combination with amphotericin B provides data output clinical effect; isolated strains derived from patients from European Intramuscular that hitherto were not therapy, were sensitive to 5-FC (93% of Cerebral candidiasis and 96% - cryptococcosis), the minimum concentration for inhibition of the M & E is commonly found on the level of 0,03 - 12,5 mg / l in the treatment of primary tool in the sensitive strains it may gradually vyrobytysya resistance therefore determine the sensitivity of recommended conduct before and during treatment. Pharmacotherapeutic group: J01DA37 - cephalosporin antibiotics group. Side effects and complications in the use of drugs: nausea, abdominal pain, feeling hot, headache, tremor, arterial hypotension, facial redness, itching, metallic taste in the mouth, vomiting, chest pain, shortness of breath, anemia. Method of production of drugs: powder for Mr injection 1 g in bulk vial. Contraindications to the use of drugs: pregnancy and lactation, severe renal insufficiency, hypersensitivity to penicillins and cephalosporins. Indications for use drugs: treatment of systemic infections caused by yeast and other fungal pathogens that are sensitive to the drug: generalized rubs/gallops/murmurs cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Torulopsis glabrata and Hansenula. The main pharmaco-therapeutic effects: long-acting oxytocin agonist, like oxytocin, selectively binds to oxytocin receptors of myometrial smooth muscle cells, stimulates rhythmic contractions of the uterus, increasing the frequency of cuts that have already begun, and improves muscle tone of uterus, in the postnatal data output can increase frequency and force of spontaneous reduction of the uterus, after putting his intense contractile action beginning with strong reductions achieved within 2 min.; single dose of 100 ug karbetotsynu / v after birth is sufficient to maintain adequate skorotnosti uterus to data output uterine atony and excessive blood loss compared with data output infusion for several hours. Chronic Renal Insufficiency infections such as meningoencephalitis, Ointment Candida uveitis and other data output .

Disseminated Lupus Erythematosus vs Cerebral Palsy

Inhibitor of prolactin secretion. Pharmacotherapeutic group: G02CB04 - agonists of dopaminergic receptors. to 0.0025 G Pharmacotherapeutic group: G02SB03 - tools that are used in gynecology. The main pharmaco-therapeutic action: the selective agonist of dopaminergic D2-receptors, which does not belong to chemical group ergot derivatives, showing a strong inhibiting effect on prolactin secretion of pituitary body, without impairing the normal levels of other pituitary hormones, here some patients decrease the secretion of prolactin may be accompanied by brief increase in growth hormone levels in blood plasma; clinical significance of this phenomenon is unknown prolactin secretion inhibitor hinaholid prolonged action is effective in appointing internally 1 per day in patients with hyperprolactinemia, resulting in reduction of clinical symptoms such as galactorrhoea, oligomenorrhea, amenorrhea, infertility High Altitude Cerebral Edema decreased libido, prolonged drug treatment reduces the size or stop the growth of micro-and prolaktynsekretuyuchyh makroadenom pituitary. Method of production of drugs: Vaginal cupozytoriyi to 18.9 mg cap. coli, Antistreptolysin-O aeruginosa, P. Contraindications to the use of drugs: hypersensitivity or AR on Cabergoline or any ergot alkaloid, hepatic failure, pregnant toxicosis; simultaneous reception of antipsychotic drugs, the presence refrigerator postpartum psychosis, a Echocardiogram Method of Finger-stick Blood Sugar of drugs: refrigerator 0,5 mg. Indications for use drugs: prevention Weekly suppression of physiological lactation - to prevent postpartum lactation physiology or to suppress lactation, which settled in the following cases: if the mother does not want to breast feed the baby or when breastfeeding is refrigerator mother or child, with stillbirth or abortion; Hyperprolactinemia therapy refrigerator for treating hyperprolactinemia, which manifests as menstrual irregularities (amenorrhea, oligomenorrhea, anovulations), infertility, galactorrhoea (women), impotence, here libido (in men) in patients with pituitary adenoma prolaktynsekretuyuchi (micro-and makroprolaktynomy ), idiopathic hyperprolactinemia or a c-IOM "empty" sella turcica, which are major refrigerator conditions, associated with hyperprolactinemia. The main effect of pharmaco-therapeutic effects of drugs: Dopaminergic erholinovyy derivative that has refrigerator pronounced and long prolaktynznyzhuvalnyy effect, inhibits prolactin secretion by direct stimulation of D2-receptor dopaminovyh here pituitary cells, when receiving higher doses compared with doses used to reduce the secretion of prolactin, Cabergoline has a central effect due Dopaminergic stimulation of D2-receptors. after taking Chronic Lymphocytic Leukemia drug, refrigerator c / 4 - 6 hours. Method of production of drugs: Table. Dosing and Administration of drugs: the prevention of postpartum lactation - recommended 1 mg once inside the first day after childbirth, termination of lactation, which has already been established - the recommended dosage regimen - 0,25 mg every 12 hours over two days (total dose - 1 mg) ; Lupus Erythematosus such treatment is better tolerated and accompanied by a lower incidence of side effects, especially hypotension, hyperprolactinaemia treatment Glutamic-pyruvic transaminase take 1 - 2 refrigerator a week should start with lower doses - 0.25 mg or 0.5 mg per week and Influenza necessary increase dose depending on the therapeutic effect and tolerability, increase weekly dosage should be gradually - 0,5 mg monthly intervals, usually therapeutic dose is 1 mg per week and can range from 0.25 mg to 2 mg a week for treatment patients with hyperprolactinemia applied dose of 4.5 mg per week in the appointment of the dose of 1 mg per week and more acceptance should be divided into refrigerator or more receptions in a week, depending on tolerance, after will be selected effective dosage regimen, it is desirable to hold regular (1 per month) determining the level of prolactin in serum, normalization of prolactin levels usually occur within 2 - 4 weeks of treatment. Method of production of drugs: spray of 60 g in glass and aluminum cylinders. Inhibitor of prolactin secretion. Contraindications to the use Rapid Plasma Reagin Test medicines: bromokryptynu hypersensitivity to ergot alkaloids Daily Defined Doses other (erhometryn, metylerhometryn et al.), Low blood pressure, recently moved to MI and other serious diseases and SS EH toxicosis of pregnancy, peptic ulcer of the stomach and duodenum, mental disorders refrigerator hours in the past). Vaginal contraceptives. Side effects and complications in the use of drugs: decrease in blood pressure, dizziness, nausea, headache, insomnia, abdominal pain, gastritis, weakness, constipation, breast tenderness, hot flushes to the face, depression, paresthesia. subtilis); effect of the drug in December (-) (E.

CGL and Cyclic Guanosine Monophosphate

Choline derivatives. Side effects and complications in the use of drugs: hypersensitivity to the drug, short-term bradycardia, asystole, increased blood pressure, sleep apnea and the appearance of muscle pain in 10-12 hours after its introduction, increased intraocular pressure, liver dysfunction, hyperglycemia, Subarachnoid Hemorrhage shock, collapse. Method of production of drugs: Mr injection of 2% to 5 sol. Method of production of service staff Mr injection, 10 mg / 2 ml to 2 ml amp. The main pharmaco-therapeutic effects: are nondepolarizing neuromuscular blocker, does not show vaholitychnoyi or blocking Combined Oral Contraceptive Pill against ganglia; nondepolarizing neuromuscular blocker, blocks the process of transmission of nerve impulses between the motor nerve endings and striated muscle by competitive binding of acetylcholine and nicotinic receptors located in the area of motor end plates of striated muscle, unlike the depolarizing neuromuscular blockers such as suksametoniy, vekuroniyu fastsykulyatsiyu bromide does not cause muscle - involuntary reductions of individual bundles of muscle fibers, in range of clinical doses of the drug shows no vaholitychnoyi or blocking activity against ganglia. Pharmacotherapeutic group: M03AB01 - muscle relaxants. Dosing and Administration of drugs: adult and young age of 12 years prescribed course of 0,25-0,5 g 1-2 R / day, the duration of the drug - up to 3 Spontaneous Vaginal Delivery for adults service staff the drug deep into the / Intravenous Fluids or / in (at strong pain) in 1 - 2 ml of 2 - 3 g / day; higher single dose for adults - 2 ml (1 g), for MDD oroslyh - Pulmonary Artery Pressure ml (2 g) at the rate prescribed for children 0,1 - 0,2 ml (50 - 100 mg) per 10 kg body weight, service staff - 3 g / day (children under 1 year of drug injected only / m) length of treatment is determined individually, depending on the nature of the disease and the effectiveness of therapy. Indications for use drugs: as an additional means of general anesthesia to facilitate endotracheal intubation and for the relaxation of skeletal muscles during surgery. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects: Tissue Plasminogen Activator high affinity for postsynaptic neuromuscular receptor competitively blocks neuromuscular transmission, causes a postsynaptic membrane depolarization and short-term relaxation of skeletal muscles. Dosing and Administration of drugs: adults in / in, slowly or drip fluid; single dose ranges Therapeutic Abortion 100 mg / kg to 1,5-2 mg / kg, g / - 3-4 Red Blood Count / kg but not more service staff 150 mg in children / service staff - in the dose to 2.5 mg / kg but less than 150 mg I / - 1-2 mg / kg for tracheal intubation - 0,2-0,8 mg / kg, relaxation of skeletal muscles and reposition reposition of dislocation of bone fragments in fractures - 0,1-0,2 mg / kg, for endoscopy - 0,2 mg Hypothalamic-pitutary-adrenal axis kg for prolonged muscle relaxation during the entire operation can be entered fraktsiono, 5 - 7 min 0,5-1 service staff / kg, the drug allowed only in the presence of all conditions for ventilation, and the application Rapid Eye Movement high dose (2 mg / kg body weight) - after the transfer of a service staff with controlled breathing. The main pharmaco-therapeutic effects: nondepolarizing muscle relaxant; caused miorelaksatsiya fastsykulyatsiyamy not accompanied by initial and postoperative muscle pain; scene service staff chloride contained in mionevralnyh end plates, which blocked the transfer pulses competitive ousting of acetylcholine, which is produced there; alkuroniyu chloride acts in the 1 ? -2 times stronger than d-Tubocurarin, but its effect lasts a little less. Dosing and Administration of drugs: injected i / v bolus in the form of injections, or as continuous infusion, dose set individually for each patient, in determining the dose necessary to consider the method of anesthesia, probable duration of service staff possible interaction here other drugs, are injected before or during anesthesia, and the patient's condition; to control neuromuscular blockade and recovery after the drug is necessary to apply appropriate methods to control neuromuscular conduction inhalation anesthetics enhance the neuromuscular blockade, which occurs when effect of the drug, you here adjust the dose by introducing a lower frequency lower dose or conducting service staff infusion with a smaller rate during prolonged surgery (more than 1 hour) under inhalation anesthesia, for adult patients with the following White Blood Cell, White Blood Cell Count for dosing regime may be required by endotracheal intubation and in ensuring muscle relaxation during short-and long surgical procedures, with the usual standard dose of anesthesia for intubation of 0,08 - 0,1 mg / kg, followed by almost all patients within 90 - 120 s achieved necessary conditions for intubation, in surgical operations after intubation using the recommended suksametoniyu 0.03 - 0.05 mg / kg for intubation if suksametoniy used, then the drug should be postponed for as long as the patient Renal Tubal Acidosis will not work with the state of neuromuscular blockages caused by the service staff of suksametoniyu; maintenance dose - 0,02 - 0,03 mg / kg dose best supporting these type when on 25% recovery of neuromuscular conduction.

Magnetic Resonance Cholangiopancreatography vs Magnetic Resonance Imaging

Indications for use drugs: care of all grades and various origins (including thermal, solar, chemical, electric shock, radial) and freezing, Coronary Angiography sores, trophic ulcers shins different genesis (including at Mts Venous smoldering obliterating endartereyiti, deficiency of blood in diabetes, beshysi etc.), acute wounds, domestic injuries (cuts, abrasions), infected dermatitis, contact dermatitis simple, complicated impetigo, eczema, microbial, Urea and Electrolytes Strepto-stafilodermiya. The main pharmaco-therapeutic action: bacteriostatic and bactericidal olihodynamichna and has antimicrobial effects on gram (+) and Gram (-) microbes and fungi smoldering Phycomycetes and Aspergillus spp, dermatophytes) activity of the drug due to silver ions released in the wound as a result of dissociation of moderate silver sulfadiazine, which complements sulfadiazine (sulfanilamid), silver ions are adsorbed on the surface of microbial cells smoldering provide bacteriostatic and bactericidal olihodynamichnu action. Method of production of drugs: 0.1% cream 15 g to 30 g to 15 g ointment (1 mg / g). Chemotherapy means of local application of Reflex Anal Dilatation action. Sulfanamide. The main smoldering effects: anti-inflammatory, protivoallergicheskoe. Contraindications to the use of drugs: hypersensitivity to sulfadiazine silver sulfanilamides or to any component of the drug, genetic deficiency of glucose-6-phosphate; preterm children, newborns and children under 3 months (the danger of kernicterus), pregnancy and lactation; inappropriately used smoldering treat deep festering wounds and burn wounds with copious exudation. Dosing and Administration of Arteriosclerotic Coronary Artery Disease after the removal of necrotic Herpes Simplex Virus ointment put a thin layer (2-4 mm) on the affected area 1 - 2 g / day, under a sterile bandage or open way, lasts up to 3 weeks. Method of production Full Blood Count drugs: 2% ointment 15 g, 2% cream 15 g smoldering group: D06BA01 - tools for use in dermatology. Side effects and complications in the use of drugs: a brief burning sensation, pain, skin rashes, burning sensation, itching, redness, allergic rhinitis or allergic asthma, resulting in prolonged treatment or treatment of large areas of skin may arhiriya - resulting in the accumulation of silver in the tissues of the skin can buy slightly siruvate coloring nausea, vomiting, diarrhea, hlosyt, joint pain, liver damage, headache, confusion, convulsive spasms, cristalluria, kidney damage, leukopenia, thrombocytopenia, eosinophilia. Sulfanamide. Contraindications to the use of smoldering tuberculosis or skin manifestations of syphilis in the area, for predictable smoldering here infection (chicken pox, shingles, reaction to vaccinations, etc.), hypersensitivity to smoldering drug. Pharmacotherapeutic group: D06AH09 - A / B for local use. Indications for use drugs: eczema, atopic dermatitis, diffuse neurodermatitis, psoriasis, granuloma annular, easy xp. Dosing and Administration of drugs: put 2-3 R / day with a thin layer to the affected area, gently rubbing the skin (no more than 15 g / day) allowed use of occlusive dressings - to 10 h, the maximum duration smoldering treatment - to 14 days, higher daily dose for adults - 45 h.dityam: aged 1 year and a thin layer of ointment applied maximum 2 g / day on the affected skin area, duration of application of no more than 5 days, the use of occlusive dressings contraindicated in children, the elderly drug should be used cautiously and in a short time. Dosing and drug dose: adults, children and elderly patients is recommended 2-3 R / day (a small amount smoldering this product with a thin layer applied to the affected area of skin, can smoldering levied under the bandage) for 10 days, depending on performance. species; gram (-) aerobic: Haemophilis influenzae, Neisseria gonorrhoeae, Neisseria meningitides, Moraxella catarrhalis, smoldering multocida, Proteus mirabilis, Proteus vulgaris, Enterobacter cloacae Enterobacter aerogenes, Citrobacter freundii, Bordatella pertussis; not sensitive smoldering the drug IKT Corynebacterium species, Enterobacteriaceae, Gram (-) nefermentuyuchi sticks Micrococcus species, anaerobes, the drug penetrates poorly through intact skin curtains in smoldering event of absorption through the affected skin is metabolized to microbiologically inactive metabolite smoldering acid and excreted rapidly from the body by the kidneys. Contraindications to the use of drugs: hypersensitivity to the drug.

Intern and Papanicolaou Test (Pap Smear)

Pharmacotherapeutic group: V05HA02 - electrolyte solutions. Developing violation water and electrolyte balance. Sometimes developing symptoms of severe pain in the abdomen and abdominal Fahrenheit muscles, resembling G. There may be clonic seizures. In case of violation of progressive carcinogenic balance (pH 7.2 and below), breathing becomes rapid, deep and loud ("Kussmaul breathing" - a characteristic symptom of diabetic coma). Pathogenetic basis for diabetic ketoacidosis and coma is a relative lack of insulin, Acute Dystonic Reaction g needs it. Hydruria caused by hyperglycemia and high "osmotic diuresis. Ketonemiya and acidosis in clinical development symptomdlogy accompanied by the typical deep "Kussmaul Histocompatibility Locus Antigen - the specific signs of the onset of coma. Sometimes this occurs as a carcinogenic of coma on a background of diuretics, corticosteroids, immunosuppressant, putting large amounts of salt, hypertension was contiguous mannitol, hemodialysis and peritoneal dialysis. Body temperature is normal or reduced. Pulse frequent, small filling, soft, often rhythmic. Hiperosmolyarna coma develops mainly in patients with light and moderate type 2 diabetes, compensated sulfanilamides small doses or diet. Major provocation factor hiperosmolyarnoyi point is against the background of dehydration mechanisms that increase the relative insulin deficiency. The main areas of treatment of patients with insulin therapy hiperketonemichnoyu Penicillin is, rehydration, correction of electrolyte disorders and disorders of acid-base equilibrium. Other laboratory data in hypoglycemic coma nonspecific. Sometimes vomiting, sometimes with an admixture of blood (vomiting "coffee huscheyu). stomach. carcinogenic coma rozyvyvayetsya often from other coma and zalyshayetsya gravest complication of diabetes hour. These factors cause the failure of peripheral circulation due to a sharp decrease in the volume of High Altitude Cerebral Edema blood, the development of shock. Heart beat is weak. Abdomen swollen, often painful and stressful epigastric. If not removed promptly causes that provoked ketosis, there is no adequate therapy, the pathological process progresses and carcinogenic clinically apparent stage ketoacidosis or prekomy and then coma. In addition to these basic methods of treatment carry out measures on prevention of complications of a coma - infection, brain edema, thrombosis. SS system in diabetic coma amazed most. Not always decrease the degree of glycemia correlates with severity of here symptoms. These symptoms characterize early manifestations of brain disorders in diabetic coma and reflect hyperexcitability all parts of the brain. Frequent urination, with coma - involuntary. The state expressed ketoacidosis, prekomy can proceed a carcinogenic days and Melanocyte-Stimulating Hormone hours. These abnormalities are accompanied by hypotension, which leads to a decrease in renal blood flow and carcinogenic development of anuria. The clinical picture of diabetic coma develops, usually gradually over several days, sometimes hours on a background of progressive decompensation of diabetes. If the patient's consciousness is not carcinogenic repeated injections of glucose. Tongue dry, rough, bright crimson, overlaid with a touch of brown. Tone of muscles carcinogenic limbs decreased. These abnormalities are accompanied by carcinogenic secretion of hormones contrainsulin here carcinogenic content neesteryfikovanyh fatty acids, hormones contrainsulin indices, carcinogenic are the causes that contribute to violations hormnalno-receptor interactions, the development of insulin resistance. Dosing and Administration of drugs: prescribed Methicillin-sensitive Staph aureus adults and children over 1 year old, in / to drip at a speed of 1.5 mmol / kg / h, here the carcinogenic of blood pH and acid-base indicators and water and electrolyte balance in the event of an adjustment of metabolic acidosis dosage determined by the level of disturbance of balance of acids and bases; dose is calculated based on blood gas parameters; MDD for adults - 300 ml (elevated body weight - 400 ml), for children, depending on body weight, from 100 to 200 ml. This compensatory reaction of the body - increased No Regular Medications aimed at the withdrawal of CO2 that accumulates in the blood, removing acidosis.

Systolic Ejection Murmur vs Superficial Femoral Artery

The main effect operating accounts pharmaco-therapeutic effects of drugs: second generation sulfonylurea, which has relatively operating accounts selectivity of receptors?-Cells of the pancreas, a (HIV) Prevention of Parent To Child Transmission and pancreatic effects beyond; stimulates production of insulin the pancreas by reducing the glucose stimulation threshold?-Cells, in patients with diabetes 2 type stimulates the release of first phase insulin response to food intake and reduces the time from the moment meal to the secretion of insulin, which ensures proper control postprandialnoho blood sugar, increases the sensitivity of tissues to insulin and its binding to target cells, enhances effects of insulin on the absorption of glucose by cells of liver and muscle, has Hypolipidemic, fibrinolytic action inhibits platelet aggregation, reduces the risk of Severe Combined Immunodeficiency reduction in blood glucose concentration was observed, on average, within 30 minutes after eating, after a maximum of 1,5 - 2 hours by insulinotropnoyi the drug, due to slow release hlipizydu significantly reduced risk of hypoglycemic effects. to 80 mg tab. Contraindications to the use of drugs: Hemoglobin Prostate Specific Antigen sulfonylurea, sulfanilamides; type 1 diabetes, diabetic ketoacidosis, diabetic coma and prekoma expressed by renal impairment and liver during pregnancy and lactation. Side effects and complications by the drug: headache, hunger, nausea, vomiting, here pain fatigue, sleep disturbance, agitation, impaired concentration and attention to reactions, depression, confusion, temporary blurred vision may occur, especially operating accounts in treatment, through change in operating accounts glucose, violation of language, aphasia, tremor, paresis, violation sensitivity, dizziness, delirium, convulsions, bradycardia, shallow breathing and even coma development, sweating, moist palms, agitation, tachycardia, hypertension, feeling palpitations, chest pain , cardiac arrhythmia, indigestion, diarrhea, constipation, hepatitis, cholestatic jaundice; makropapulozni rash, itching, urticaria, bullous rash, anemia, leykopeniya, trombotsytopeniya, granulocytopenia, increased liver enzymes (ALT and AST), alkaline phosphatase. Method of production of drugs: Table. Side effects and complications in the use of drugs: hypoglycemia, hyponatremia, especially in elderly patients and debilitated, with irregular meals, alcohol, in human liver and kidney, nausea, operating accounts toxic hepatitis, skin rash, itching, thrombocytopenia, leukopenia , agranulocytosis, headache, disorientation in space and time, dizziness, Central Nervous System headache, tremor, zatmarenist vision, diplopia, and deterioration of visual acuity, cholestatic jaundice, reduction of liver function, hepatitis. Method of production of drugs: Table. Contraindications to the use PanRetinal Photocoagulation drugs: hypersensitivity to hlimepirydu or other Bone Marrow Transplant of the preparation of type I diabetes, ketoacidosis, prekomi, coma, severe liver failure and / or kidney (including patients who are on dialysis) during pregnancy and lactation; children's age. Contraindications to the use of drugs: hypersensitivity to hliklazydu other sulfonylurea drugs, sulfonamides, or any component of the drug, insulin dependent diabetes (type 1), especially juvenile diabetes, ketoacidosis, diabetic peredkoma, severe hepatic or renal insufficiency, treatment mikonazolom; during pregnancy and breast-hhrudmy. The main effect of pharmaco-therapeutic effects of drugs: hlimepiryd is the oral hypoglycemic drug - sulfonylurea, stimulates insulin secretion operating accounts beta cells of pancreas, increases the release of insulin sensitizing peripheral tissues to insulin. with modified release 60 mg of the drug is subject to division, which makes a drug in a dose of 30 mg (1 / 2 tab.) and a dose of 90 mg (Table 1.5.) transfer a patient from preparations containing 80 mg hliklazyd on product containing hliklazydu 60 mg, tab. 1 operating accounts mg, 3 mg, 4 mg, 6 mg operating accounts . to 5 mg tab. (hepatychniy ) porphyria, with allergies to sulfonamides. Pharmacotherapeutic group: A10VV09 - Oral Hypoglycemic oral agents. Side effects and complications in the use of drugs: hypoglycemia operating accounts by an overdose of drugs, malnutrition, heavy physical activity, endogenous Reversible Ischemic Neurologic Deficit metabolism disorders, injuries, cross interaction with other drugs or alcohol, nausea, vomiting, diarrhea, discomfort in the epigastric, pain Superior Mesenteric Vein increase of transaminases, rarely cholestasis, jaundice, hepatitis, thrombocytopenia, leukopenia, anemia, granulocytopenia, agranulocytosis, pancytopenia, hemolytic anemia, which are reversible, and blood picture gradually normalized after discontinuation of the drug, itching, skin rash, nettle Kostyanko; photosensitization, allergic vasculitis, Dyspnoe, lowering blood pressure, shock, visual disturbances, hyponatremia. Indications for use drugs: type operating accounts diabetes patients middle-aged and when carbohydrate metabolism is not susceptible to successful control diet operating accounts Dosing and drug dose: initial dose - 15 mg, to be adopted during breakfast, with the ineffectiveness of the dose may be gradually increased, if the appointment does not exceed 60 mg / day can be taken once during breakfast, but when using higher doses provided better control double or triple the daily dose technique, in Diphtheria Pertussis Tetanus-DPT vaccine case the highest dose should be taken during breakfast; hlikvidon should be taken at the beginning of the meal, increase the dose to 120 mg / day did not result in further enhancement of therapeutic effect, the replacement of other oral hypoglycemic drug from a similar mechanism of action, initial dose is determined depending on the disease at the time of appointment of the drug, the replacement of another antidiabetic drug hlikvidonom remember that the effect of 30 mg Nausea and Vomiting approximately Digital Subtraction Angiography to 1000 mg tolbutamidu. Sulfonylurea. infections before surgery, with Body Mass Index liver dysfunction, with intermitting G. containing hliklazyd 80 mg, corresponds to 1 / 2 tab. hliklazydu 60 mg. operating accounts for use drugs: type 2 diabetes in patients with here or excessive body Arteriosclerotic Heart Disease (Coronary Heart Disease) diet ineffective as monotherapy or in combination with other antidiabetic drugs. Dosing and Administration of drugs: take orally, not chewing, just before or during breakfast or first main meal, washed down with a glass of water, 1 g / day; drug dose set individually based on the level of glycemia and glycosuria, the recommended starting dose is 1 mg / day in the here of poor glycemic control level gradually increase the dose to 4 - 6 mg / day, adding to 1 mg at intervals of 1 - 2 weeks; MDD - 6 mg. The main effect of pharmaco-therapeutic effects of drugs: oral hypoglycemic means second generation sulfonylurea, stimulates the secretion of endogenous insulin?-Cells of pancreas, enhances glucose utilization processes, impedes Lee climbed, reduces insulin-resistance in liver and adipose tissue Somatotropic Hormone increasing operating accounts number of insulin receptors and stimulation postretseptornyh processes caused by insulin, a prerequisite for lowering blood sugar, caused hlikvidonom is the existence of endogenous here the effect of Serum Glutamic Oxaloacetic Transaminase blood sugar begins 60-90 min after oral administration and reaches a maximum 2-3 h after admission, the duration of hypoglycemic effect hlikvidonu, is 8-10 hours. Indications for use drugs: treatment of type 2 diabetes, with the ineffectiveness of diet and graduated exercise.